Remedy Robotics Partners with Mission Thrombectomy
Remedy Robotics has entered a strategic partnership with Mission Thrombectomy, a leadin…
TCT 2025: STORM-PE Trial Demonstrates Safety and Efficacy of Mechanical Thrombectomy in Intermediate-High-Risk Pulmonary Embolism
The STOR…
Repligen: Q3 Earnings Snapshot
Repligen (RGEN) reported third-quarter net income of $14.9 million, with a profit of 26 cents per share.
The Betami-Danblock Trial
The BETAMI-DANBLOCK trial evaluates the safety of discontinuing beta-blockers after myocardial infarction (MI) i…
Eavor's Geothermal Project Milestones
Eavor, an advanced-geothermal startup, has reduced drilling times and improved performance at its cl…
Regulatory Approval for Cultivated Chicken
PARIMA, a French cultivated meat company, has received regulatory approval from the Singapore F…
Cameco and Brookfield Involved in $80 Billion U.S. Nuclear Reactor Deal
The government has agreed to an $80 billion deal with Westinghouse…
UK Administrations Update: October 21-27
Since our last update, several businesses have been confirmed as having fallen into administratio…
Hope Bancorp: Q3 Earnings Snapshot
Hope Bancorp Inc. (HOPE) reported third-quarter net income of $30.8 million, with earnings of 24 cents …
Brookfield/Cameco-owned Westinghouse Secures US Nuclear Construction Deal
Westinghouse Electric, a nuclear power firm owned by Brookfield …